Elyxyb — Medica
acute treatment of migraine with or without aura in adults
Preferred products
- triptans (e.g., almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan)
Initial criteria
- Patient has a diagnosis of migraine requiring acute treatment
- age ≥ 18 years
- ONE of the following: (a) patient has tried at least one triptan therapy; OR (b) prescriber states patient has a contraindication to triptans (e.g., history of coronary artery disease, cardiac accessory conduction pathway disorders, stroke, transient ischemic attack, hemiplegic or basilar migraine, peripheral vascular disease, ischemic bowel disease, uncontrolled hypertension, or severe hepatic impairment)
Approval duration
1 year